Avexitide, which has been granted FDA breakthrough therapy designation, has shown significant effectiveness in treating Postbariatric Hypoglycemia (PBH) and congenital hyperinsulinism, and is expected to commence Phase 3 trials for PBH by early 2025
But in the last few years, like the other medications mentioned earlier, something unexpected has happened
Tirzepatide is an expensive medication that costs around $400-500 per month without insurance through LillyDirect
Current guidelines recommend discontinuing semaglutide at least 2 months before planned conception due to its long half-life
In the UK, Wegovy is typically prescribed through specialist weight management services according to NICE guidance (TA875)
Diarrhea on Mounjaro occurs because the medication affects how your intestines absorb water and move contents through your digestive tract